The market for vaginal slings has been growing steadily as a result of the increase in the prevalence of SUI across the world. The vaginal slings are often utilized in the surgical interventions meant for giving support to the urethra to prevent the involuntary passage of urine. They have gained immense popularity because of the benefits that they offer such as efficacy and minimal invasiveness. There has been increased recognition of women’s health problems which explains why more people seek medical solutions.
There has been an increased adoption of vaginal sling surgeries due to their efficiency and recovery periods. These surgical procedures are minimally invasive and require shorter stays at the hospital. They also allow the patients to resume their routine activities after a shorter period of time compared to other surgical options.
The Vaginal Slings Market size was estimated at USD 1.72 billion in 2025 and is expected to reach USD 2.78 billion by 2035, growing at a CAGR of 4.92% during the forecast period 2026–2035.
Major Manufacturers Expanding the Vaginal Slings Market
Boston Scientific
Boston Scientific is one of athe world leaders in manufacturing medical devices and has a significant focus on the field of urology and pelvic health therapies. Boston Scientific produces a variety of vaginal sling systems to help patients overcome their problems with stress urinary incontinence. The main strengths of the company include innovation, safety, and effectiveness due to high-quality product design. The company remains highly committed to further developing its product line through research and development to promote minimally invasive therapies.
Coloplast
Coloplast is a company known for offering solutions for intimate healthcare needs of women. This manufacturer also has a variety of products in the field of urology and continence care, which include vaginal slings. The core strengths of the company include innovation and clinical focus. Coloplast actively develops its product line in the sphere of pelvic health treatments.
Ethicon (Johnson & Johnson)
The Ethicon Company from the Johnson & Johnson group is a leader in surgical and medical technology. The company develops advanced techniques that can be used in minimally invasive operations and vaginal sling systems. They strive to provide more precision and safer surgery. The Ethicon Company benefits from its global experience to support health care providers with quality products. The company's powerful R&D processes lead to innovations in surgeries.
Medtronic
The Medtronic Company is a global health care technology company providing medical devices for different urological diseases and other purposes. The company strives to develop advanced minimally invasive therapies. Vaginal slings developed by Medtronic provide more effective and long-term treatment for diseases. The company keeps making investments into innovation and clinical studies.
Clinical and Market Trends Supporting Industry Expansion
Market drivers include increasing occurrence of stress urinary incontinence in aging population and post-childbirth women. Awareness regarding stress incontinence is gradually increasing. Consequently, many patients have begun looking for surgical treatment rather than opting for nonsurgical management approaches. Demand for effective and sustainable surgical treatment like vaginal slings will be consequently increased due to higher awareness levels.
Preference for less invasive treatment approaches can also be cited as a key driver of growth in the global vaginal slings market. There are numerous benefits associated with performing vaginal slings surgery, such as faster recovery, reduction in the number of complications, and fewer days in the hospital. Therefore, it is expected that growing preference for less invasive surgical methods will positively influence market growth.
Product development activities are also promoting growth in the industry. Increasing focus on improvement in design and material quality can be seen as an effort to promote the safety of devices, improve their performance, and increase their durability.
Availability of healthcare services and advancements in surgical procedures can also be considered as important drivers behind market growth. Availability of appropriate surgical techniques and healthcare infrastructure is increasing rapidly in the industry.
How Innovation Is Shaping the Next Phase of Vaginal Sling Treatments
It is anticipated that the market for vaginal slings will grow steadily as the healthcare industry concentrates on the improvement of the outcomes of women's health. Investments in research, innovations in products, and conducting clinical trials will be done by manufacturers in order to improve safety and efficacy of the procedures.
Driven by the increased demand for minimally invasive therapies, manufacturers are expected to introduce new products that are designed better. This is expected to increase the importance of vaginal slings in stress urinary incontinence.
Growing awareness, increased prevalence, and continuous innovations in surgical procedures are expected to contribute to the continued prominence of vaginal slings as an important solution within the field of urology.
